FDA lists 20 drugs under review for safety risks

09/7/2008 | Wall Street Journal, The

The FDA released a list of 20 medicines being investigated for potential adverse effects to provide early warnings to consumers and health care professionals. The list includes Eli Lilly and Co.'s Cymbalta, an antidepressant, and Purdue Pharma's OxyContin, a pain medication. Companies expressed support for the agency's drug-safety efforts, but some are concerned that data presented to patients lack context and may affect the course of their treatment.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA